British Journal of Clinical Pharmacology · 1977 · 55 citations · 22 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryPain MedicineStructure-activity RelationshipsAnalgesiaAnalgesic PharmacologyAnti-inflammatory PharmacologyInflammation PharmacologyAnalgesic Anti-inflammatory PharmacologyAnalgesic Drug DevelopmentAnti-inflammatory TherapeuticsNonsteroidal Anti-inflammatory Drug PharmacologyPharmacological Pain ReliefPharmacological PotencyPotency ComparisonPotency Measurement
I Diflunisal (MK-647; 5-(2,4-difluorophenyl)-salicylic acid) is a new analgesic anti-inflammatory agent discovered after an extensive chemical and pharmacological study from 1962-71. 2 In the search for a superior salicylate our objectives were higher potency, better tolerance, and a longer duration of action. 3 An evaluation of many available and newly synthesized salicylates, in the granuloma and carrageenan foot oedema assays, revealed the activity-enhancing trend of a hydrophobic group-for example, phenyl, at the carbon-5 position of salicylic acid. 4 The attachment of a 5-(4-fluorophenyl) group, previously found to enhance the potency of antiinflammatory (3,2-c)-pyrazole steroids and phenyl-a-propionic acids to acetyl salicylic acid yielded a clinical candidate flufenisal. As an analgesic, flufenisal is two times more potent than aspirin in man, but with a longer action; no distinct advantage in gastrointestinal tolerance has, however, been observed. 5 Further investigation of 5-heteroaryl salicylic acids, flufenisal congeners and their non-acylating carbonate esters identified diflunisal and 5-( l-pyrryl)-salicylic acid for subacute safety assessment. The O-acetyl group, commonly present in aspirin, benorylate and flufenisal, was purposely avoided in these two compounds for safety considerations. 6 Without an O-acetyl group, diflunisal cannot acetylate proteins and macro-molecules in vivo as aspirin does. In the prostaglandin synthetase assay in vitro, salicylic acid is much less active than aspirin. In contrast, the non-acetylated diflunisal and desacetyl flufenisal are both more active than flufenisal in vitro. A significant difference between aspirin and diflunisal in their biochemical mechanisms was noted. 7 On the basis of overall efficacy and tolerance data, diflunisal was finally chosen as a superior analgesic anti-inflammatory salicylate for clinical evaluation.
22
<b>Non-Steroid Anti-Inflammatory Agents</b>
T. Y. Shen, Thomas B. Windholz, Avery Rosegay et al. · Journal of the American Chemical Society · 1963 · 174 citations · Full text